Full Text View
Tabular View
No Study Results Posted
Related Studies
Serp-1 for the Treatment of Acute Coronary Syndrome
This study has been terminated.
( Third dose group not recruited due to slow enrollment. )
Study NCT00243308   Information provided by Viron Therapeutics Inc

First Received on October 19, 2005.   Last Updated on February 5, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Unstable Angina
Coronary Atherosclerosis
Coronary Restenosis
Additional conditions recognized in this trial
Acute Coronary Syndrome
Angina Pectoris
Angina, Unstable
Atherosclerosis
Coronary Artery Disease
Myocardial Infarction
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Chest Pain
Coronary Disease
Coronary Stenosis
Heart Diseases
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Serine proteinase-1 (Serp-1)
Additional drug interventions recognized in this trial
Anti-Inflammatory Agents
More general drug interventions related to this trial
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Viron Therapeutics Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services